Drug Development
ArQule initiates toxicology studies of RQ 171
Published in Cancer Weekly, March 28th, 2006
"With the initiation of these studies, we are taking an important step toward the clinic with a second compound from our E2F1 checkpoint pathway program, based on our alliance with Roche," said Stephen A. Hill, president and chief executive officer of ArQule. "If data from these studies with ARQ 171 are supportive, the next step in the development process for ARQ 171 will be the filing of an investigational new drug application."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-03-28)
More Articles from Cancer Weekly
- Cancer Diagnostics
Intramucosal carcinoma and dysplasia detected by optical coherence tomography - Drug Development
N-(7-indazolyl)benzenesulfonamide derivatives identified as potent cell cycle inhibitors - Hepatocellular Cancer
Hepatocellular cancer survival linked to racial differences - Melanoma
Platelet-activating factor acts as promoter of melanoma metastasis - Adenocarcinomas
Fibroblast growth factor has oncogenic activity in ovarian endometrioid adenocarcinomas - Adenocarcinomas
Occupational physical activity linked to possible decreased adenocarcinoma risk - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
